Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2020.06.115
Abstract: Hsp90 chaperone is an encouraging target for the development of novel anticancer agents. The failure of Hsp90 inhibitors to get regulatory approval for the treatment of cancer is hindered due to toxicity, cost involved in… read more here.
Keywords: hsp90; recent update; hsp90 inhibitors; senolytic agents ... See more keywords